Sanctus Global Formulations Profile
Key Indicators
- Authorised Capital ₹ 4.50 Cr
as on 06-07-2024
- Paid Up Capital ₹ 4.16 Cr
as on 06-07-2024
- Company Age 24 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.08 Cr
as on 06-07-2024
- Satisfied Charges ₹ 34.67 Cr
as on 06-07-2024
- Revenue -2.52%
(FY 2023)
- Profit -47.77%
(FY 2023)
- Ebitda 27.85%
(FY 2023)
- Net Worth -9.37%
(FY 2023)
- Total Assets -0.51%
(FY 2023)
About Sanctus Global Formulations
The Corporate was formerly known as Crescent Therapeutics Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 Cr and a paid-up capital of Rs 4.16 Cr.
The company currently has active open charges totaling ₹18.08 Cr. The company has closed loans amounting to ₹34.67 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vijay Joshi, Sahil Joshi, and Sangeeta Joshi serve as directors at the Company.
- CIN/LLPIN
U29297CH2000PLC041530
- Company No.
041530
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Nov 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sanctus Global Formulations?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Joshi  | Director | 01-Oct-2016 | Current |
| Sahil Joshi | Director | 02-Dec-2016 | Current |
| Sangeeta Joshi | Director | 06-Jan-2023 | Current |
Financial Performance of Sanctus Global Formulations.
Sanctus Global Formulations Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.52% decrease. The company also saw a substantial fall in profitability, with a 47.77% decrease in profit. The company's net worth dipped by a decrease of 9.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanctus Global Formulations?
In 2023, Sanctus Global Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sanctus Global Lifesciences Private LimitedActive 7 years 10 monthsVijay Joshi and Sahil Joshi are mutual person
- Vikson Securities Private LimitedActive 29 years 6 months
Vijay Joshi and Sangeeta Joshi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Jan 2024 | ₹3.00 Cr | Open |
Others Creation Date: 23 Nov 2022 | ₹1.25 Cr | Open |
Others Creation Date: 12 Nov 2021 | ₹9.90 M | Open |
How Many Employees Work at Sanctus Global Formulations?
Sanctus Global Formulations has a workforce of 108 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanctus Global Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanctus Global Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
